Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: 2024's Women of Influence
Admissions
Finance
Higher expenses, payer denials blunt CHS' Q3 earnings
CHS' third-quarter earnings were dampened by a continued increase in payer denials and coding downgrades as well as losses from Hurricane Helene.
Heather Landi
Oct 25, 2024 4:00pm
Tenet CEO: Post-COVID demand spike will wind down after 2025
Sep 4, 2024 5:00pm
Market volatility persists amid stubborn expense challenges
Jul 31, 2024 7:30am
Community Health Systems slims losses in Q2
Jul 25, 2024 1:00pm
Tenet reports $259M net income and raises guidance
Jul 24, 2024 7:22am
33 provider groups urge Biden to address 'gridlocked' EDs
Nov 10, 2022 8:00am